HCV IMMUNOTHERAPY

The invention relates to the use of Interleukin-7 (IL-7), for treating hepatitis C in a patient infected with hepatitis C virus, wherein said patient has been treated or is being treated with an antiviral agent or a combination of antiviral agents that reduces viral load.

Saved in:
Bibliographic Details
Main Authors BEQ, STEPHANIE, MORRE, MICHEL, DEMOL, PIERRE, ASSOULINE, BRIGITTE, CROUGHS, THÉRÈSE
Format Patent
LanguageEnglish
French
German
Published 11.06.2014
Subjects
Online AccessGet full text

Cover

Loading…